JPY 1039.0
(-0.86%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.57 Billion | 2.13 Billion | 1.8 Billion | 1.76 Billion | 1.79 Billion | 1.87 Billion |
Net Income | 1.58 Billion | 1.08 Billion | 1.03 Billion | 745.51 Million | 903.19 Million | 935.76 Million |
Depreciation & Amortization | 1.02 Billion | 983.2 Million | 1.02 Billion | 959.08 Million | 858.2 Million | 804.16 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 150.65 Million | 56.31 Million | -200.3 Million | -62.17 Million | 44.07 Million | 68.86 Million |
Other non-cash items | 2.02 Billion | 2.01 Billion | 1.98 Billion | 2.3 Billion | 1.71 Billion | 1.66 Billion |
Investing Cash Flow | 8.3 Million | -2.3 Billion | -1.79 Billion | -3.79 Billion | -1.36 Billion | -1.61 Billion |
Investments in PPE | -617.42 Million | -2.31 Billion | -1.81 Billion | -3.8 Billion | -1.27 Billion | -1.63 Billion |
Acquisitions | 632.44 Million | - | - | - | - | - |
Investment purchases | -1.25 Billion | -1.25 Billion | -1.24 Billion | -1.24 Billion | -1.26 Billion | -1.27 Billion |
Sales/Maturities of investments | 1.24 Billion | 1.24 Billion | 1.24 Billion | 1.26 Billion | 1.26 Billion | 1.28 Billion |
Other Investing Activities | -2.02 Million | 6.81 Million | 23.6 Million | -4.47 Million | -85.54 Million | 16.34 Million |
Financing Cash Flow | -1.5 Billion | 344.51 Million | 959.61 Million | 1.43 Billion | -148.52 Million | 322.96 Million |
Debt repayment | -1.12 Billion | -705.64 Million | -1.13 Billion | -1.66 Billion | -25.75 Million | -522.14 Million |
Dividends payments | -375.93 Million | -361 Million | -174.27 Million | -224.07 Million | -174.27 Million | -199.17 Million |
Common Stock Repurchased | -55 Thousand | -123 Thousand | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -100 Million | -1000.00 | - | -26.6 Million | - | - |
Accounts receivables | -152.19 Million | -90 Million | -55.64 Million | 16.22 Million | 9.34 Million | 190.57 Million |
Accounts payables | -7.32 Million | 62.4 Million | -102.43 Million | -105.48 Million | -17.6 Million | -183.26 Million |
Inventory | - | -82 Thousand | 175.7 Million | -174.92 Million | -999 Thousand | 820 Thousand |
Other working capital | 310.16 Million | 84 Million | -217.92 Million | 202.01 Million | 53.34 Million | 60.73 Million |
Cash at beginning of period | 4.01 Billion | 3.84 Billion | 2.87 Billion | 3.47 Billion | 3.18 Billion | 2.6 Billion |
Cash at end of period | 5.09 Billion | 4.01 Billion | 3.84 Billion | 2.87 Billion | 3.47 Billion | 3.18 Billion |
Capital Expenditure | -617.42 Million | -2.31 Billion | -1.81 Billion | -3.8 Billion | -1.27 Billion | -1.63 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 1.07 Billion | 173.25 Million | 970.74 Million | -597.05 Million | 282.89 Million | 585 Million |
Free Cash Flow | 1.95 Billion | -172.42 Million | -9.14 Million | -2.04 Billion | 519.74 Million | 237.31 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 400 Million | 250 Million | 1.58 Billion | 587 Million | 361 Million | 385 Million |
Depreciation & Amortization | - | - | 1.02 Billion | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 150.65 Million | - | - | - |
Other non-cash items | -400 Million | -250 Million | 2.02 Billion | -587 Million | -361 Million | -385 Million |
Investing Cash Flow | - | - | 8.3 Million | - | - | - |
Investments in PPE | - | - | -617.42 Million | - | - | - |
Acquisitions | - | - | 632.44 Million | - | - | - |
Investment purchases | - | - | -1.25 Billion | - | - | - |
Sales/Maturities of investments | - | - | 1.24 Billion | - | - | - |
Other Investing Activities | - | - | -2.02 Million | - | - | - |
Financing Cash Flow | - | - | -1.5 Billion | - | - | - |
Debt repayment | - | - | -1.12 Billion | - | - | - |
Dividends payments | - | - | -375.93 Million | - | - | - |
Common Stock Repurchased | - | - | -55 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | -152.19 Million | - | - | - |
Accounts payables | - | - | -7.32 Million | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 310.16 Million | - | - | - |
Cash at beginning of period | - | - | 4.01 Billion | - | - | - |
Cash at end of period | - | - | 5.09 Billion | - | - | - |
Capital Expenditure | - | - | -617.42 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 1.07 Billion | - | - | - |
Free Cash Flow | - | - | 1.95 Billion | - | - | - |
NOX
3002
000320
3624
MEDICO
FPH